TWST's logo.
Ticker Symbol: TWST

Twist Bioscience Corp

$115.99 - 02-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001581280

Company Profile

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by 'writing' DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: 681 Gateway Blvd.
CEO: Emily Leproust
Tags:
  • Health Technology
  • Biotechnology

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $18.37
Change: -$0.80 ( -4.17%)
Days Range: $18.09 - $19.41
Beta: 2.56
52wk. High: $40.50
52wk. Low: $11.46
Ytd. Change -23.66%
50 Day Moving Average: $20.01
200 Day Moving Average: $18.53
Shares Outstanding: 57396131

Valuation

Market Cap: 105.4B
PE Ratio: -4.95
EPS (TTM): -3.71

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A